Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Return on Sales (2016 - 2025)

Historic Return on Sales for Pharma-Bio Serv (PBSV) over the last 17 years, with Q4 2025 value amounting to 0.0%.

  • Pharma-Bio Serv's Return on Sales fell 100.0% to 0.0% in Q4 2025 from the same period last year, while for Oct 2025 it was 0.01%, marking a year-over-year increase of 700.0%. This contributed to the annual value of 0.01% for FY2025, which is 700.0% up from last year.
  • Latest data reveals that Pharma-Bio Serv reported Return on Sales of 0.0% as of Q4 2025, which was down 100.0% from 0.11% recorded in Q3 2025.
  • Pharma-Bio Serv's Return on Sales' 5-year high stood at 0.46% during Q3 2021, with a 5-year trough of 0.87% in Q4 2021.
  • Moreover, its 5-year median value for Return on Sales was 0.04% (2022), whereas its average is 0.01%.
  • Its Return on Sales has fluctuated over the past 5 years, first plummeted by -9000bps in 2021, then skyrocketed by 9100bps in 2022.
  • Over the past 5 years, Pharma-Bio Serv's Return on Sales (Quarter) stood at 0.87% in 2021, then surged by 104bps to 0.04% in 2022, then crashed by -135bps to 0.01% in 2023, then soared by 153bps to 0.01% in 2024, then plummeted by -101bps to 0.0% in 2025.
  • Its Return on Sales was 0.0% in Q4 2025, compared to 0.11% in Q3 2025 and 0.04% in Q2 2025.